The Joint Corp. Announces the Resignation of Steven P. Colmar from the Board of Directors
March 20 2017 - 8:00AM
The Joint Corp. (NASDAQ:JYNT), a national operator, manager and
franchisor of chiropractic clinics, today announced the resignation
of Steven P. Colmar from the company’s board of directors. Mr.
Colmar’s resignation is effective as of March 17, 2017.
Peter D. Holt, The Joint Corp.’s President and Chief Executive
Officer stated, “On behalf of the organization, we wish to thank
Mr. Colmar for his dedication and service to the company and our
board of directors. The nominating and governance committee of the
board of directors is currently evaluating director candidates to
fill the vacancy, and such candidates will be presented for
election at the 2017 annual meeting of stockholders.”
About The Joint
Corp. (NASDAQ:JYNT)
Based in Scottsdale, Arizona, The Joint is an emerging growth
company that is reinventing chiropractic by making quality care
convenient and affordable for patients seeking pain relief and
ongoing wellness. Its no-appointment policy and convenient hours
and locations make care more accessible, and affordable membership
plans and packages eliminate the need for insurance. With 350+
clinics nationwide and more than 3 million patient visits annually,
The Joint is a key leader in the chiropractic profession. For
more information, visit www.thejoint.com or follow the brand
on Twitter, Facebook, YouTube and LinkedIn.
Business Structure The Joint Corp. is a
franchisor of clinics and an operator of clinics in certain states.
In Arkansas, California, Colorado, Florida, Illinois, Kansas,
Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon,
Pennsylvania, and Tennessee, The Joint Corp. and its franchisees
provide management services to affiliated professional chiropractic
practices.
Forward-Looking Statements This press release
contains statements about future events and expectations that
constitute forward-looking statements. Forward-looking
statements are based on our beliefs, assumptions and expectations
of industry trends, our future financial and operating performance
and our growth plans, taking into account the information currently
available to us. These statements are not statements of
historical fact. Forward-looking statements involve risks and
uncertainties that may cause our actual results to differ
materially from the expectations of future results we express or
imply in any forward-looking statements and you should not place
undue reliance on such statements. Factors that could
contribute to these differences include, but are not limited to,
our failure to develop or acquire corporate clinics as rapidly as
we intend, our failure to profitably operate corporate clinics, and
the factors described in “Risk Factors” in The Joint Corp.’s 2016
Annual Report on Form 10-K. Words such as "anticipates",
"believes", "continues", "estimates", "expects", "goal",
"objectives", "intends", "may", "opportunity", "plans",
"potential", "near-term", "long-term", "projections",
"assumptions", "projects", "guidance", "forecasts", "outlook",
"target", "trends", "should", "could", "would", "will" and similar
expressions are intended to identify such forward-looking
statements. We qualify any forward-looking statements entirely by
these cautionary factors. We assume no obligation to update
or revise any forward-looking statements for any reason, or to
update the reasons actual results could differ materially from
those anticipated in these forward-looking statements, even if new
information becomes available in the future. Comparisons of
results for current and any prior periods are not intended to
express any future trends or indications of future performance,
unless expressed as such, and should only be viewed as historical
data.
Investor Contact:
Peter Vozzo
peter.vozzo@westwicke.com
443-213-0505
Media Contact:
Inna Lazarev
Public Relations Manager
inna.lazarev@thejoint.com
Joint (NASDAQ:JYNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Joint (NASDAQ:JYNT)
Historical Stock Chart
From Apr 2023 to Apr 2024